Results 21 to 30 of about 25,400 (245)

Incidence of hospital-acquired toxin-producing clostridioides difficile infection between the pre-pandemic (2017–2019) and pandemic (2020–2022): a retrospective cohort study [PDF]

open access: yesArchives of Public Health
Background In 2020, the World Health Organization declared SARS-CoV-2 a global public health emergency. Healthcare systems were forced to reorganize care delivery and implement wide-ranging infection control strategies. Among hospital-acquired infections,
Raquel García Rodríguez   +4 more
doaj   +2 more sources

Uncovering the Harms of Treating Clostridioides difficile Colonization

open access: yesmSphere, 2021
Patients with toxin-negative Clostridioides ...
Christopher R. Polage   +1 more
doaj   +2 more sources

Mortality Attributable to Clostridioides difficile Infection: The Rising Burden of Disease in European Countries

open access: yesMedicina
Background and Objectives: Clostridioides difficile infection is a major public health issue, being among the main causes of mortality due to healthcare-associated diarrhea.
Irena Ilic   +2 more
doaj   +2 more sources

Clostridioides difficile Biofilm

open access: yes
Clostridioides difficile infection (CDI), previously Clostridium difficile infection, is a symptomatic infection of the large intestine caused by the spore-forming anaerobic, gram-positive bacterium Clostridioides difficile. CDI is an important healthcare-associated disease worldwide, characterized by high levels of recurrence, morbidity, and mortality.
Vuotto, C.   +3 more
openaire   +4 more sources

Epidemiological characteristics of infections caused by bacteria Clostridioides difficile toxins [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo
Introduction/Objective. Clostridioides difficile is one of the most common infectious agents and an important cause of infections among hospitalized patients, often resulting in severe and potentially fatal outcomes.
Koprivica Marko, Đekić-Malbaša Jelena
doaj   +2 more sources

Current and future approaches in Clostridioides Difficile management [PDF]

open access: yesRomanian Journal of Infectious Diseases, 2022
Clostridioides Difficile is considered one of the main causes of the healthcare associated infections worldwide and the main cause of antibiotic-associated diarrhea, with forms of clinical disease ranging from mild to deadly.
George Sebastian Gherlan
doaj   +1 more source

A Review of Therapies for Clostridioides difficile Infection

open access: yesAntibiotics
Clostridioides difficile is an urgent public health threat that affects approximately half a million patients annually in the United States. Despite concerted efforts aimed at the prevention of Clostridioides difficile infection (CDI), it remains a ...
Faiza Morado, Neha Nanda
doaj   +2 more sources

Infective Endocarditis by Clostridioides and Clostridium Species—A Narrative Review

open access: yesAntibiotics, 2023
Bacteria of the genus Clostridium are anaerobic Gram-positive spore-forming bacilli that include more than 200 species. Some of them are known to cause invasive infections and diseases caused by the production of toxins.
Petros Ioannou   +4 more
doaj   +1 more source

Molecular epidemiology and antimicrobial resistance of Clostridioides difficile in Germany, 2014–2019

open access: yesInternational Journal of Medical Microbiology, 2021
Clostridioides difficile is a Gram positive spore-forming rod and mainly responsible for nosocomial diarrhea in developed nations. Molecular and antimicrobial surveillance is important for monitoring the strain composition including genotypes of high ...
Ahmed Mohamed Mostafa Abdrabou   +9 more
doaj   +1 more source

Clostridioides difficile [PDF]

open access: yesTrends in Microbiology, 2018
Clostridioides difficile is a spore-forming, anaerobic, intestinal pathogen that causes severe diarrhea that can lead to death. In 2011, C. difficile infected ∼500000 people in the USA and killed ∼29000 people. C. difficile infection (CDI) is the most common healthcare-related infection in the USA, leading to increased healthcare costs of $4.8 billion.
Brindar K, Sandhu, Shonna M, McBride
openaire   +2 more sources

Home - About - Disclaimer - Privacy